Exploding with momentum: CBDL shatters records with 622% revenue growth in five months, propelling to a 1,405% year-to-date increase-a game-changer in the CBD industry.

UDS Health and Relentless Health jointly announce the launch of their collaboration to bring simple, accurate PFAS testing to fire departments across the US.

Powered by Aptevo's proprietary ADAPTIR-FLEX^®platform, antibody innovation targeting difficult-to-treat cancers

~ $10 Million Commitment from Specialty Drug Manufacturer to Support Commercialization Efforts ~

Liom, formerly known as Spiden, a pioneer in non-invasive biomarker monitoring aiming to develop the first non-invasive glucose monitoring wearable, is thrilled to announce significant technological milestones and a successful kick-off of its Series A.

MobilityWorks has opened a new location in the Raleigh community to provide those with limited mobility access to wheelchair accessible vehicles, services and resources.

HITRUST r2 Certification validates Jorie AI is committed to strong cybersecurity and protecting sensitive data.

GJK Facility Services Director George Stamas Delivers Closing Speech

- STAR-1 topline results expected in March 2025 -

- Over 30 million acne patients seek treatment in the U.S. each year -

- Phase 2b for DMT310 achieved statistically significant results for all primary endpoints -

Focused Ultrasound Therapy for tremors is now available for patients with Dr. Taghva in Orange County

Diarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the veterinary emergency room, yet there are currently no FDA-approved drugs to treat general diarrhea in dogs

New trials to evaluate IGC-AD1's potential impact on amyloid plaque, tau tangles, and cognitive decline in Alzheimer's disease

Expanded research positions IGC-AD1 as a potential treatment targeting the underlying disease pathology of Alzheimer's

VELOXA® Very Low Oxalate Teas SCIENTIFICALLY TESTED

Bringing yet another clinical breakthrough to the 2024 RSNA Annual Meeting, AGFA HealthCare is excited to announce a new partnership with CARPL.ai - the world's largest radiology AI marketplace.

Renowned expert Dr. Rubinstein to train practitioners on new BOTOX® technique for smoother neck contours in New York.

Ankle & Foot Centers of America's Columbus office, led by Dr. Jennifer Monaco, partners with the Job Training Division of Columbus, GA, to offer hands-on internships for aspiring healthcare professionals. This unique program provides students with real-world experience in podiatric medicine, fostering skills and inspiring future careers in healthcare.

Self Regional Healthcare aims to upgrade its PACS, enhance diagnostic imaging capabilities, and strengthen its financial position while optimizing staff workflows. By adopting AGFA HealthCare's Enterprise Imaging Cloud, they are poised to successfully achieve these objectives.

Renowned Facial Plastic Surgeon Dr. Rubinstein has been selected to train professionals on FDA-approved BOTOX® Cosmetic for neck rejuvenation in New Jersey. 

Aptevo's Peter Pavlik, PhD, to chair a session on "Bi and Multispecific Biologics" and will also give talk titled "Modular Multispecific Biotherapeutics: Rapid Therapeutic Design with the ADAPTIR™ Platform" at Cambridge Healthcare Institute's, Pep Talk 2025

~ Landmark Overdose Protection Clinical Trial of PF614-MPAR ~

~ Expects Early Interim Data in 1Q 2025 ~

Unlocking the Mysteries of Consciousness: SIDHE Institute Launches Groundbreaking Research and Transformative Programs Merging Ancient Wisdom with Modern Science to Revolutionize Mental Health Treatment. Explore Uncharted Territories of the Mind Through Psychedelic Experiences, Archetypal Psychology, and Personalized Psilocybin Protocols Designed to Empower Individuals, Transcend Societal Limitations, and Redefine Humanity's Relationship with Reality.

Princeton Health Magazine features Dr. Yamasaki on modern approaches to treating Bell's Palsy.

During National Diabetes Awareness Month, the major multi-state podiatry group emphasizes how its advanced vascular care for diabetic foot complications can prevent severe complications and help patients maintain their mobility and way of life.

Wellstack and Hartford HealthCare Partner to Drive Innovation in Data Integration and Patient-Centered Care

Diarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the veterinary emergency room, yet there are currently no FDA-approved drugs to treat general diarrhea in dogs

Canalevia^®-CA1, Jaguar's first-generation antisecretory drug for the treatment of chemotherapy-induced diarrhea in dogs, has received extension of conditional approval by FDA

Developing innovative bispecific antibodies for monotherapy and combination with the potential to expand the frontiers of cancer treatment